Search and Browse
Download
Enter Data
| Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kJ/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Lysine-specific histone demethylase 1A (Homo sapiens (Human)) | BDBM283129 (4-[2-(4-amino-piperidin-1-yl)-5- (4-methoxyphenyl)...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <100 | n/a | n/a | n/a | n/a | n/a | n/a |
Celgene Corporation US Patent | Assay Description This assay determines the ability of a test compound to inhibit LSD-1 demethylase activity. E. coli expressed full-length human LSD-1 (Accession numb... | US Patent US10328077 (2019) BindingDB Entry DOI: 10.7270/Q2W66P3N | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Lysine-specific histone demethylase 1A (Homo sapiens (Human)) | BDBM283200 (4-[2-(4-amino-piperidin-1-yl)-5-(4- methoxyphenyl)...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <100 | n/a | n/a | n/a | n/a | n/a | n/a |
Celgene Corporation US Patent | Assay Description This assay determines the ability of a test compound to inhibit LSD-1 demethylase activity. E. coli expressed full-length human LSD-1 (Accession numb... | US Patent US10328077 (2019) BindingDB Entry DOI: 10.7270/Q2W66P3N | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Lysine-specific histone demethylase 1A (Homo sapiens (Human)) | BDBM283272 (2-fluoro-4-[5-(4-methoxy-phenyl)- 1-methyl-2-(meth...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <100 | n/a | n/a | n/a | n/a | n/a | n/a |
Celgene Corporation US Patent | Assay Description This assay determines the ability of a test compound to inhibit LSD-1 demethylase activity. E. coli expressed full-length human LSD-1 (Accession numb... | US Patent US10328077 (2019) BindingDB Entry DOI: 10.7270/Q2W66P3N | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Lysine-specific histone demethylase 1A (Homo sapiens (Human)) | BDBM283281 (4-[2-(3-amino-azetidin-1-yl)-5- (4-methoxy-phenyl)...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <100 | n/a | n/a | n/a | n/a | n/a | n/a |
Celgene Corporation US Patent | Assay Description This assay determines the ability of a test compound to inhibit LSD-1 demethylase activity. E. coli expressed full-length human LSD-1 (Accession numb... | US Patent US10328077 (2019) BindingDB Entry DOI: 10.7270/Q2W66P3N | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Lysine-specific histone demethylase 1A (Homo sapiens (Human)) | BDBM342173 (4-[2-(4-amino-piperidin-1-yl)-5- (1H-indol-5-yl)-1...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <100 | n/a | n/a | n/a | n/a | n/a | n/a |
Celgene Corporation US Patent | Assay Description This assay determines the ability of a test compound to inhibit LSD-1 demethylase activity. E. coli expressed full-length human LSD-1 (Accession numb... | US Patent US10328077 (2019) BindingDB Entry DOI: 10.7270/Q2W66P3N | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Lysine-specific histone demethylase 1A (Homo sapiens (Human)) | BDBM283216 (4-[2-(4-amino-piperidin-1-yl)-5- (3-fluoro-4-metho...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <100 | n/a | n/a | n/a | n/a | n/a | n/a |
Celgene Corporation US Patent | Assay Description This assay determines the ability of a test compound to inhibit LSD-1 demethylase activity. E. coli expressed full-length human LSD-1 (Accession numb... | US Patent US10328077 (2019) BindingDB Entry DOI: 10.7270/Q2W66P3N | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Lysine-specific histone demethylase 1A (Homo sapiens (Human)) | BDBM342194 (4-[2-(4-aminopiperidin-1-yl)-5-(6- ethoxypyridin-3...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <100 | n/a | n/a | n/a | n/a | n/a | n/a |
Celgene Corporation US Patent | Assay Description This assay determines the ability of a test compound to inhibit LSD-1 demethylase activity. E. coli expressed full-length human LSD-1 (Accession numb... | US Patent US10328077 (2019) BindingDB Entry DOI: 10.7270/Q2W66P3N | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Lysine-specific histone demethylase 1A (Homo sapiens (Human)) | BDBM289960 (4-[2-(4-aminopiperidin- 1-yl)-5-(3,5-difluoropheny...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <100 | n/a | n/a | n/a | n/a | n/a | n/a |
Celgene Corporation US Patent | Assay Description This assay determines the ability of a test compound to inhibit LSD-1 demethylase activity. E. coli expressed full-length human LSD-1 (Accession numb... | US Patent US10328077 (2019) BindingDB Entry DOI: 10.7270/Q2W66P3N | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Lysine-specific histone demethylase 1A (Homo sapiens (Human)) | BDBM283128 (4-(2-(4-aminopiperidin-1-yl)- 1-methyl-6-oxo-5-p-t...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <100 | n/a | n/a | n/a | n/a | n/a | n/a |
Celgene Corporation US Patent | Assay Description This assay determines the ability of a test compound to inhibit LSD-1 demethylase activity. E. coli expressed full-length human LSD-1 (Accession numb... | US Patent US10328077 (2019) BindingDB Entry DOI: 10.7270/Q2W66P3N | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Lysine-specific histone demethylase 1A (Homo sapiens (Human)) | BDBM283224 (4-[2-(4-amino-piperidin-1-yl)-5- cyclopentylethyny...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <100 | n/a | n/a | n/a | n/a | n/a | n/a |
Celgene Corporation US Patent | Assay Description This assay determines the ability of a test compound to inhibit LSD-1 demethylase activity. E. coli expressed full-length human LSD-1 (Accession numb... | US Patent US10328077 (2019) BindingDB Entry DOI: 10.7270/Q2W66P3N | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Lysine-specific histone demethylase 1A (Homo sapiens (Human)) | BDBM283237 (4-[2-((3R)-3-aminopiperidyl)-5- (3-fluoro-4-methox...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <100 | n/a | n/a | n/a | n/a | n/a | n/a |
Celgene Corporation US Patent | Assay Description This assay determines the ability of a test compound to inhibit LSD-1 demethylase activity. E. coli expressed full-length human LSD-1 (Accession numb... | US Patent US10328077 (2019) BindingDB Entry DOI: 10.7270/Q2W66P3N | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Lysine-specific histone demethylase 1A (Homo sapiens (Human)) | BDBM289889 (4-[2-(4-amino-4-methyl-piperidin- 1-yl)-5-(3-fluor...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <100 | n/a | n/a | n/a | n/a | n/a | n/a |
Celgene Corporation US Patent | Assay Description This assay determines the ability of a test compound to inhibit LSD-1 demethylase activity. E. coli expressed full-length human LSD-1 (Accession numb... | US Patent US10328077 (2019) BindingDB Entry DOI: 10.7270/Q2W66P3N | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Lysine-specific histone demethylase 1A (Homo sapiens (Human)) | BDBM283267 (5-[2-(4-amino-piperidin-1-yl)-4- (4-cyano-3-fluoro...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <100 | n/a | n/a | n/a | n/a | n/a | n/a |
Celgene Corporation US Patent | Assay Description This assay determines the ability of a test compound to inhibit LSD-1 demethylase activity. E. coli expressed full-length human LSD-1 (Accession numb... | US Patent US10328077 (2019) BindingDB Entry DOI: 10.7270/Q2W66P3N | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Lysine-specific histone demethylase 1A (Homo sapiens (Human)) | BDBM283276 (4-[2-(4-amino-piperidin-1-yl)-5- (4-dimethylamino-...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <100 | n/a | n/a | n/a | n/a | n/a | n/a |
Celgene Corporation US Patent | Assay Description This assay determines the ability of a test compound to inhibit LSD-1 demethylase activity. E. coli expressed full-length human LSD-1 (Accession numb... | US Patent US10328077 (2019) BindingDB Entry DOI: 10.7270/Q2W66P3N | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Lysine-specific histone demethylase 1A (Homo sapiens (Human)) | BDBM283286 (4-[2-(3-aminomethyl-azetidin-1-yl)- 5-(4-methoxy-p...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <100 | n/a | n/a | n/a | n/a | n/a | n/a |
Celgene Corporation US Patent | Assay Description This assay determines the ability of a test compound to inhibit LSD-1 demethylase activity. E. coli expressed full-length human LSD-1 (Accession numb... | US Patent US10328077 (2019) BindingDB Entry DOI: 10.7270/Q2W66P3N | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Lysine-specific histone demethylase 1A (Homo sapiens (Human)) | BDBM342189 (4-[5-(4-aminophenyl)-2-(4- aminopiperidin-1-yl)-1-...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <100 | n/a | n/a | n/a | n/a | n/a | n/a |
Celgene Corporation US Patent | Assay Description This assay determines the ability of a test compound to inhibit LSD-1 demethylase activity. E. coli expressed full-length human LSD-1 (Accession numb... | US Patent US10328077 (2019) BindingDB Entry DOI: 10.7270/Q2W66P3N | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Lysine-specific histone demethylase 1A (Homo sapiens (Human)) | BDBM289947 (4-[2-(4-aminopiperidin-1- yl)-1-methyl-5-[4- (meth...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <100 | n/a | n/a | n/a | n/a | n/a | n/a |
Celgene Corporation US Patent | Assay Description This assay determines the ability of a test compound to inhibit LSD-1 demethylase activity. E. coli expressed full-length human LSD-1 (Accession numb... | US Patent US10328077 (2019) BindingDB Entry DOI: 10.7270/Q2W66P3N | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Lysine-specific histone demethylase 1A (Homo sapiens (Human)) | BDBM283222 (2-fluoro-4-[5-(3-fluoro-4-methoxy- phenyl)-1-methy...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <100 | n/a | n/a | n/a | n/a | n/a | n/a |
Celgene Corporation US Patent | Assay Description This assay determines the ability of a test compound to inhibit LSD-1 demethylase activity. E. coli expressed full-length human LSD-1 (Accession numb... | US Patent US10328077 (2019) BindingDB Entry DOI: 10.7270/Q2W66P3N | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Lysine-specific histone demethylase 1A (Homo sapiens (Human)) | BDBM283226 (2-[2-(4-amino-piperidin-1-yl)-4- (4-cyano-3-fluoro...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <100 | n/a | n/a | n/a | n/a | n/a | n/a |
Celgene Corporation US Patent | Assay Description This assay determines the ability of a test compound to inhibit LSD-1 demethylase activity. E. coli expressed full-length human LSD-1 (Accession numb... | US Patent US10328077 (2019) BindingDB Entry DOI: 10.7270/Q2W66P3N | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Lysine-specific histone demethylase 1A (Homo sapiens (Human)) | BDBM283228 (4-[2-(4-amino-piperidin-1-yl)-5- benzofuran-5-yl-1...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <100 | n/a | n/a | n/a | n/a | n/a | n/a |
Celgene Corporation US Patent | Assay Description This assay determines the ability of a test compound to inhibit LSD-1 demethylase activity. E. coli expressed full-length human LSD-1 (Accession numb... | US Patent US10328077 (2019) BindingDB Entry DOI: 10.7270/Q2W66P3N | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Lysine-specific histone demethylase 1A (Homo sapiens (Human)) | BDBM283234 (4-[2-(2,8-diaza-spiro[4.5]dec-8-yl)- 5-(3-fluoro-4...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <100 | n/a | n/a | n/a | n/a | n/a | n/a |
Celgene Corporation US Patent | Assay Description This assay determines the ability of a test compound to inhibit LSD-1 demethylase activity. E. coli expressed full-length human LSD-1 (Accession numb... | US Patent US10328077 (2019) BindingDB Entry DOI: 10.7270/Q2W66P3N | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Lysine-specific histone demethylase 1A (Homo sapiens (Human)) | BDBM283235 (4-{2-(4-aminopiperidyl)-1-methyl- 6-oxo-5-[6-(trif...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <100 | n/a | n/a | n/a | n/a | n/a | n/a |
Celgene Corporation US Patent | Assay Description This assay determines the ability of a test compound to inhibit LSD-1 demethylase activity. E. coli expressed full-length human LSD-1 (Accession numb... | US Patent US10328077 (2019) BindingDB Entry DOI: 10.7270/Q2W66P3N | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Lysine-specific histone demethylase 1A (Homo sapiens (Human)) | BDBM283238 (4-[2-(4-aminopiperidyl)-5-(5- fluoro-6-methoxy(3-5...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <100 | n/a | n/a | n/a | n/a | n/a | n/a |
Celgene Corporation US Patent | Assay Description This assay determines the ability of a test compound to inhibit LSD-1 demethylase activity. E. coli expressed full-length human LSD-1 (Accession numb... | US Patent US10328077 (2019) BindingDB Entry DOI: 10.7270/Q2W66P3N | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Lysine-specific histone demethylase 1A (Homo sapiens (Human)) | BDBM283241 (4-[2-((3S)-3-amino-piperidin-1- yl)-5-(3-fluoro-4-...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <100 | n/a | n/a | n/a | n/a | n/a | n/a |
Celgene Corporation US Patent | Assay Description This assay determines the ability of a test compound to inhibit LSD-1 demethylase activity. E. coli expressed full-length human LSD-1 (Accession numb... | US Patent US10328077 (2019) BindingDB Entry DOI: 10.7270/Q2W66P3N | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Lysine-specific histone demethylase 1A (Homo sapiens (Human)) | BDBM283247 (4-[2-(4-aminopiperidyl)-1-methyl- 5-(1-methyl(1H-i...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <100 | n/a | n/a | n/a | n/a | n/a | n/a |
Celgene Corporation US Patent | Assay Description This assay determines the ability of a test compound to inhibit LSD-1 demethylase activity. E. coli expressed full-length human LSD-1 (Accession numb... | US Patent US10328077 (2019) BindingDB Entry DOI: 10.7270/Q2W66P3N | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Lysine-specific histone demethylase 1A (Homo sapiens (Human)) | BDBM283263 (4-[2-[1,4]diazepan-1-yl-5-(3-fluoro- 4-methoxy-phe...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <100 | n/a | n/a | n/a | n/a | n/a | n/a |
Celgene Corporation US Patent | Assay Description This assay determines the ability of a test compound to inhibit LSD-1 demethylase activity. E. coli expressed full-length human LSD-1 (Accession numb... | US Patent US10328077 (2019) BindingDB Entry DOI: 10.7270/Q2W66P3N | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Lysine-specific histone demethylase 1A (Homo sapiens (Human)) | BDBM283270 (2-fluoro-4-[5-(4-methoxy-phenyl)- 1-methyl-6-oxo-2...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <100 | n/a | n/a | n/a | n/a | n/a | n/a |
Celgene Corporation US Patent | Assay Description This assay determines the ability of a test compound to inhibit LSD-1 demethylase activity. E. coli expressed full-length human LSD-1 (Accession numb... | US Patent US10328077 (2019) BindingDB Entry DOI: 10.7270/Q2W66P3N | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Lysine-specific histone demethylase 1A (Homo sapiens (Human)) | BDBM283273 (2-fluoro-4-[5-(4-methoxy-phenyl)- 1-methyl-2-(meth...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <100 | n/a | n/a | n/a | n/a | n/a | n/a |
Celgene Corporation US Patent | Assay Description This assay determines the ability of a test compound to inhibit LSD-1 demethylase activity. E. coli expressed full-length human LSD-1 (Accession numb... | US Patent US10328077 (2019) BindingDB Entry DOI: 10.7270/Q2W66P3N | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Lysine-specific histone demethylase 1A (Homo sapiens (Human)) | BDBM283280 (4-[2-[1,4]diazepan-1-yl-5- (6-dimethylamino-pyridi...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <100 | n/a | n/a | n/a | n/a | n/a | n/a |
Celgene Corporation US Patent | Assay Description This assay determines the ability of a test compound to inhibit LSD-1 demethylase activity. E. coli expressed full-length human LSD-1 (Accession numb... | US Patent US10328077 (2019) BindingDB Entry DOI: 10.7270/Q2W66P3N | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Lysine-specific histone demethylase 1A (Homo sapiens (Human)) | BDBM283290 (4-[2-(4-dimethylamino-piperidin-1- yl)-1-methyl-5-...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <100 | n/a | n/a | n/a | n/a | n/a | n/a |
Celgene Corporation US Patent | Assay Description This assay determines the ability of a test compound to inhibit LSD-1 demethylase activity. E. coli expressed full-length human LSD-1 (Accession numb... | US Patent US10328077 (2019) BindingDB Entry DOI: 10.7270/Q2W66P3N | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Lysine-specific histone demethylase 1A (Homo sapiens (Human)) | BDBM283295 (4-[2-(4-amino-piperidin-1-yl)-1- methyl-5-(1-methy...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <100 | n/a | n/a | n/a | n/a | n/a | n/a |
Celgene Corporation US Patent | Assay Description This assay determines the ability of a test compound to inhibit LSD-1 demethylase activity. E. coli expressed full-length human LSD-1 (Accession numb... | US Patent US10328077 (2019) BindingDB Entry DOI: 10.7270/Q2W66P3N | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Lysine-specific histone demethylase 1A (Homo sapiens (Human)) | BDBM283297 (4-[2-((4R,3S)-4-amino-3-fluoro- piperidin-1-yl)-5-...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <100 | n/a | n/a | n/a | n/a | n/a | n/a |
Celgene Corporation US Patent | Assay Description This assay determines the ability of a test compound to inhibit LSD-1 demethylase activity. E. coli expressed full-length human LSD-1 (Accession numb... | US Patent US10328077 (2019) BindingDB Entry DOI: 10.7270/Q2W66P3N | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Lysine-specific histone demethylase 1A (Homo sapiens (Human)) | BDBM283309 (2-fluoro-4-[1-methyl-2- [4-(methylamino)piperidin-...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <100 | n/a | n/a | n/a | n/a | n/a | n/a |
Celgene Corporation US Patent | Assay Description This assay determines the ability of a test compound to inhibit LSD-1 demethylase activity. E. coli expressed full-length human LSD-1 (Accession numb... | US Patent US10328077 (2019) BindingDB Entry DOI: 10.7270/Q2W66P3N | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Lysine-specific histone demethylase 1A (Homo sapiens (Human)) | BDBM342207 (4-[2-(4-aminopiperidin-1-yl)-5-[4- (methoxymethyl)...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <100 | n/a | n/a | n/a | n/a | n/a | n/a |
Celgene Corporation US Patent | Assay Description This assay determines the ability of a test compound to inhibit LSD-1 demethylase activity. E. coli expressed full-length human LSD-1 (Accession numb... | US Patent US10328077 (2019) BindingDB Entry DOI: 10.7270/Q2W66P3N | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Lysine-specific histone demethylase 1A (Homo sapiens (Human)) | BDBM283218 (4-[2-(4-amino-piperidin-1-yl)-5- (6-methoxy-pyridi...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <100 | n/a | n/a | n/a | n/a | n/a | n/a |
Celgene Corporation US Patent | Assay Description This assay determines the ability of a test compound to inhibit LSD-1 demethylase activity. E. coli expressed full-length human LSD-1 (Accession numb... | US Patent US10328077 (2019) BindingDB Entry DOI: 10.7270/Q2W66P3N | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Lysine-specific histone demethylase 1A (Homo sapiens (Human)) | BDBM283239 (4-[2-((3R)-3-aminopyrrolidinyl)- 5-(3-fluoro-4-met...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <100 | n/a | n/a | n/a | n/a | n/a | n/a |
Celgene Corporation US Patent | Assay Description This assay determines the ability of a test compound to inhibit LSD-1 demethylase activity. E. coli expressed full-length human LSD-1 (Accession numb... | US Patent US10328077 (2019) BindingDB Entry DOI: 10.7270/Q2W66P3N | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Lysine-specific histone demethylase 1A (Homo sapiens (Human)) | BDBM283253 (4-[2-(4-aminopiperidyl)-5- (3,5-difluoro-4-methoxy...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <100 | n/a | n/a | n/a | n/a | n/a | n/a |
Celgene Corporation US Patent | Assay Description This assay determines the ability of a test compound to inhibit LSD-1 demethylase activity. E. coli expressed full-length human LSD-1 (Accession numb... | US Patent US10328077 (2019) BindingDB Entry DOI: 10.7270/Q2W66P3N | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Lysine-specific histone demethylase 1A (Homo sapiens (Human)) | BDBM283255 (US10023543, Example 40 | US10207999, Example 40 | ...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <100 | n/a | n/a | n/a | n/a | n/a | n/a |
Celgene Corporation US Patent | Assay Description This assay determines the ability of a test compound to inhibit LSD-1 demethylase activity. E. coli expressed full-length human LSD-1 (Accession numb... | US Patent US10328077 (2019) BindingDB Entry DOI: 10.7270/Q2W66P3N | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Lysine-specific histone demethylase 1A (Homo sapiens (Human)) | BDBM283291 (4-[2-(4-dimethylamino-piperidin-1- yl)-1-methyl-5-...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <100 | n/a | n/a | n/a | n/a | n/a | n/a |
Celgene Corporation US Patent | Assay Description This assay determines the ability of a test compound to inhibit LSD-1 demethylase activity. E. coli expressed full-length human LSD-1 (Accession numb... | US Patent US10328077 (2019) BindingDB Entry DOI: 10.7270/Q2W66P3N | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Lysine-specific histone demethylase 1A (Homo sapiens (Human)) | BDBM289954 (4-[2-(4-aminopiperidin- 1-yl)-5-[4-(2- hydroxyetho...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <100 | n/a | n/a | n/a | n/a | n/a | n/a |
Celgene Corporation US Patent | Assay Description This assay determines the ability of a test compound to inhibit LSD-1 demethylase activity. E. coli expressed full-length human LSD-1 (Accession numb... | US Patent US10328077 (2019) BindingDB Entry DOI: 10.7270/Q2W66P3N | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Lysine-specific histone demethylase 1A (Homo sapiens (Human)) | BDBM289958 (4-[2-(4-aminopiperidin- 1-yl)-5-(4-fluorophenyl)-1...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <100 | n/a | n/a | n/a | n/a | n/a | n/a |
Celgene Corporation US Patent | Assay Description This assay determines the ability of a test compound to inhibit LSD-1 demethylase activity. E. coli expressed full-length human LSD-1 (Accession numb... | US Patent US10328077 (2019) BindingDB Entry DOI: 10.7270/Q2W66P3N | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Lysine-specific histone demethylase 1A (Homo sapiens (Human)) | BDBM289961 (4-[2-(4-aminopiperidin- 1-yl)-5-(3,4-difluoropheny...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <100 | n/a | n/a | n/a | n/a | n/a | n/a |
Celgene Corporation US Patent | Assay Description This assay determines the ability of a test compound to inhibit LSD-1 demethylase activity. E. coli expressed full-length human LSD-1 (Accession numb... | US Patent US10328077 (2019) BindingDB Entry DOI: 10.7270/Q2W66P3N | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Lysine-specific histone demethylase 1A (Homo sapiens (Human)) | BDBM283199 (4-[2-(4-amino-piperidin-1-yl)-1- methyl-5-(6-methy...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <100 | n/a | n/a | n/a | n/a | n/a | n/a |
Celgene Corporation US Patent | Assay Description This assay determines the ability of a test compound to inhibit LSD-1 demethylase activity. E. coli expressed full-length human LSD-1 (Accession numb... | US Patent US10328077 (2019) BindingDB Entry DOI: 10.7270/Q2W66P3N | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Lysine-specific histone demethylase 1A (Homo sapiens (Human)) | BDBM283215 (4-[2-(4-amino-piperidin-1-yl)-5- (4-methoxyphenyl)...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <100 | n/a | n/a | n/a | n/a | n/a | n/a |
Celgene Corporation US Patent | Assay Description This assay determines the ability of a test compound to inhibit LSD-1 demethylase activity. E. coli expressed full-length human LSD-1 (Accession numb... | US Patent US10328077 (2019) BindingDB Entry DOI: 10.7270/Q2W66P3N | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Lysine-specific histone demethylase 1A (Homo sapiens (Human)) | BDBM283216 (4-[2-(4-amino-piperidin-1-yl)-5- (3-fluoro-4-metho...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <100 | n/a | n/a | n/a | n/a | n/a | n/a |
Celgene Corporation US Patent | Assay Description This assay determines the ability of a test compound to inhibit LSD-1 demethylase activity. E. coli expressed full-length human LSD-1 (Accession numb... | US Patent US10328077 (2019) BindingDB Entry DOI: 10.7270/Q2W66P3N | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Lysine-specific histone demethylase 1A (Homo sapiens (Human)) | BDBM283217 (4-[2-(4-amino-piperidin-1-yl)-5- (6-methoxypyridin...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <100 | n/a | n/a | n/a | n/a | n/a | n/a |
Celgene Corporation US Patent | Assay Description This assay determines the ability of a test compound to inhibit LSD-1 demethylase activity. E. coli expressed full-length human LSD-1 (Accession numb... | US Patent US10328077 (2019) BindingDB Entry DOI: 10.7270/Q2W66P3N | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Lysine-specific histone demethylase 1A (Homo sapiens (Human)) | BDBM283221 (2-fluoro-4-[5-(4-methoxy-phenyl)- 1-methyl-2-(4-me...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <100 | n/a | n/a | n/a | n/a | n/a | n/a |
Celgene Corporation US Patent | Assay Description This assay determines the ability of a test compound to inhibit LSD-1 demethylase activity. E. coli expressed full-length human LSD-1 (Accession numb... | US Patent US10328077 (2019) BindingDB Entry DOI: 10.7270/Q2W66P3N | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Lysine-specific histone demethylase 1A (Homo sapiens (Human)) | BDBM283233 (2-fluoro-4-[1-methyl-2- (4-methylamino-piperidin-1...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <100 | n/a | n/a | n/a | n/a | n/a | n/a |
Celgene Corporation US Patent | Assay Description This assay determines the ability of a test compound to inhibit LSD-1 demethylase activity. E. coli expressed full-length human LSD-1 (Accession numb... | US Patent US10328077 (2019) BindingDB Entry DOI: 10.7270/Q2W66P3N | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Lysine-specific histone demethylase 1A (Homo sapiens (Human)) | BDBM283243 (4-[2-((3R)-3-aminopiperidyl)-5- (4-methoxyphenyl)-...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <100 | n/a | n/a | n/a | n/a | n/a | n/a |
Celgene Corporation US Patent | Assay Description This assay determines the ability of a test compound to inhibit LSD-1 demethylase activity. E. coli expressed full-length human LSD-1 (Accession numb... | US Patent US10328077 (2019) BindingDB Entry DOI: 10.7270/Q2W66P3N | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Lysine-specific histone demethylase 1A (Homo sapiens (Human)) | BDBM283294 (4-[2-(4-amino-piperidin-1-yl)-5- (1H-indol-6-yl)-1...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <100 | n/a | n/a | n/a | n/a | n/a | n/a |
Celgene Corporation US Patent | Assay Description This assay determines the ability of a test compound to inhibit LSD-1 demethylase activity. E. coli expressed full-length human LSD-1 (Accession numb... | US Patent US10328077 (2019) BindingDB Entry DOI: 10.7270/Q2W66P3N | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Lysine-specific histone demethylase 1A (Homo sapiens (Human)) | BDBM283299 (4-[2-(4-dimethylamino-piperidin-1- yl)-1-methyl-5-...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <100 | n/a | n/a | n/a | n/a | n/a | n/a |
Celgene Corporation US Patent | Assay Description This assay determines the ability of a test compound to inhibit LSD-1 demethylase activity. E. coli expressed full-length human LSD-1 (Accession numb... | US Patent US10328077 (2019) BindingDB Entry DOI: 10.7270/Q2W66P3N | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Lysine-specific histone demethylase 1A (Homo sapiens (Human)) | BDBM289959 (4-[2-(4-aminopiperidin- 1-yl)-5-(3-fluorophenyl)- ...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <100 | n/a | n/a | n/a | n/a | n/a | n/a |
Celgene Corporation US Patent | Assay Description This assay determines the ability of a test compound to inhibit LSD-1 demethylase activity. E. coli expressed full-length human LSD-1 (Accession numb... | US Patent US10328077 (2019) BindingDB Entry DOI: 10.7270/Q2W66P3N | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Lysine-specific histone demethylase 1A (Homo sapiens (Human)) | BDBM289962 (4-[2-(4-aminopiperidin- 1-yl)-1-methyl-5-(4- methy...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <100 | n/a | n/a | n/a | n/a | n/a | n/a |
Celgene Corporation US Patent | Assay Description This assay determines the ability of a test compound to inhibit LSD-1 demethylase activity. E. coli expressed full-length human LSD-1 (Accession numb... | US Patent US10328077 (2019) BindingDB Entry DOI: 10.7270/Q2W66P3N | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Lysine-specific histone demethylase 1A (Homo sapiens (Human)) | BDBM283134 (4-[2-(4-amino-piperidin-1-yl)-5- (6-methoxypyridin...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <100 | n/a | n/a | n/a | n/a | n/a | n/a |
Celgene Corporation US Patent | Assay Description This assay determines the ability of a test compound to inhibit LSD-1 demethylase activity. E. coli expressed full-length human LSD-1 (Accession numb... | US Patent US10328077 (2019) BindingDB Entry DOI: 10.7270/Q2W66P3N | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Lysine-specific histone demethylase 1A (Homo sapiens (Human)) | BDBM283220 (4-[2-(4-amino-piperidin-1-yl)-5-(6- ethyl-pyridin-...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <100 | n/a | n/a | n/a | n/a | n/a | n/a |
Celgene Corporation US Patent | Assay Description This assay determines the ability of a test compound to inhibit LSD-1 demethylase activity. E. coli expressed full-length human LSD-1 (Accession numb... | US Patent US10328077 (2019) BindingDB Entry DOI: 10.7270/Q2W66P3N | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Lysine-specific histone demethylase 1A (Homo sapiens (Human)) | BDBM283232 (4-[2-(4-aminopiperidin-1-yl)-5- chloro-1-methyl-6-...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <100 | n/a | n/a | n/a | n/a | n/a | n/a |
Celgene Corporation US Patent | Assay Description This assay determines the ability of a test compound to inhibit LSD-1 demethylase activity. E. coli expressed full-length human LSD-1 (Accession numb... | US Patent US10328077 (2019) BindingDB Entry DOI: 10.7270/Q2W66P3N | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Lysine-specific histone demethylase 1A (Homo sapiens (Human)) | BDBM283236 (4-[2-(4-aminopiperidyl)-1-methyl- 5-(2-methyl(2H-i...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <100 | n/a | n/a | n/a | n/a | n/a | n/a |
Celgene Corporation US Patent | Assay Description This assay determines the ability of a test compound to inhibit LSD-1 demethylase activity. E. coli expressed full-length human LSD-1 (Accession numb... | US Patent US10328077 (2019) BindingDB Entry DOI: 10.7270/Q2W66P3N | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Lysine-specific histone demethylase 1A (Homo sapiens (Human)) | BDBM283242 (4-[2-((3S)-3-amino-pyrrolidin-1-yl)- 5-(3-fluoro-4...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <100 | n/a | n/a | n/a | n/a | n/a | n/a |
Celgene Corporation US Patent | Assay Description This assay determines the ability of a test compound to inhibit LSD-1 demethylase activity. E. coli expressed full-length human LSD-1 (Accession numb... | US Patent US10328077 (2019) BindingDB Entry DOI: 10.7270/Q2W66P3N | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Lysine-specific histone demethylase 1A (Homo sapiens (Human)) | BDBM283249 (4-{2-(4-amino-piperidin-1-yl)-1- methyl-6-oxo-5-[1...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <100 | n/a | n/a | n/a | n/a | n/a | n/a |
Celgene Corporation US Patent | Assay Description This assay determines the ability of a test compound to inhibit LSD-1 demethylase activity. E. coli expressed full-length human LSD-1 (Accession numb... | US Patent US10328077 (2019) BindingDB Entry DOI: 10.7270/Q2W66P3N | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Lysine-specific histone demethylase 1A (Homo sapiens (Human)) | BDBM283251 (4-{2-(4-amino-piperidin-1-yl)-1- methyl-6-oxo-5-[1...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <100 | n/a | n/a | n/a | n/a | n/a | n/a |
Celgene Corporation US Patent | Assay Description This assay determines the ability of a test compound to inhibit LSD-1 demethylase activity. E. coli expressed full-length human LSD-1 (Accession numb... | US Patent US10328077 (2019) BindingDB Entry DOI: 10.7270/Q2W66P3N | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Lysine-specific histone demethylase 1A (Homo sapiens (Human)) | BDBM283256 (4-[2-(4-aminopiperidyl)-6- (4-cyanophenyl)-3-methy...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <100 | n/a | n/a | n/a | n/a | n/a | n/a |
Celgene Corporation US Patent | Assay Description This assay determines the ability of a test compound to inhibit LSD-1 demethylase activity. E. coli expressed full-length human LSD-1 (Accession numb... | US Patent US10328077 (2019) BindingDB Entry DOI: 10.7270/Q2W66P3N | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Lysine-specific histone demethylase 1A (Homo sapiens (Human)) | BDBM283260 (4-{5-(3-fluoro-4-methoxy-phenyl)- 1-methyl-6-oxo-2...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <100 | n/a | n/a | n/a | n/a | n/a | n/a |
Celgene Corporation US Patent | Assay Description This assay determines the ability of a test compound to inhibit LSD-1 demethylase activity. E. coli expressed full-length human LSD-1 (Accession numb... | US Patent US10328077 (2019) BindingDB Entry DOI: 10.7270/Q2W66P3N | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Lysine-specific histone demethylase 1A (Homo sapiens (Human)) | BDBM283265 (4-[5-(3-fluoro-4-methoxy-phenyl)- 1-methyl-6-oxo-2...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <100 | n/a | n/a | n/a | n/a | n/a | n/a |
Celgene Corporation US Patent | Assay Description This assay determines the ability of a test compound to inhibit LSD-1 demethylase activity. E. coli expressed full-length human LSD-1 (Accession numb... | US Patent US10328077 (2019) BindingDB Entry DOI: 10.7270/Q2W66P3N | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Lysine-specific histone demethylase 1A (Homo sapiens (Human)) | BDBM283269 (2-fluoro-4-{5-(4-methoxy-phenyl)- 1-methyl-6-oxo-2...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <100 | n/a | n/a | n/a | n/a | n/a | n/a |
Celgene Corporation US Patent | Assay Description This assay determines the ability of a test compound to inhibit LSD-1 demethylase activity. E. coli expressed full-length human LSD-1 (Accession numb... | US Patent US10328077 (2019) BindingDB Entry DOI: 10.7270/Q2W66P3N | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Lysine-specific histone demethylase 1A (Homo sapiens (Human)) | BDBM283271 (2-fluoro-4-[5-(4-methoxy-phenyl)- 1-methyl-2-(meth...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <100 | n/a | n/a | n/a | n/a | n/a | n/a |
Celgene Corporation US Patent | Assay Description This assay determines the ability of a test compound to inhibit LSD-1 demethylase activity. E. coli expressed full-length human LSD-1 (Accession numb... | US Patent US10328077 (2019) BindingDB Entry DOI: 10.7270/Q2W66P3N | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Lysine-specific histone demethylase 1A (Homo sapiens (Human)) | BDBM283275 (2-fluoro-4-[5-(6-methoxy-pyridin-3- yl)-1-methyl-2...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <100 | n/a | n/a | n/a | n/a | n/a | n/a |
Celgene Corporation US Patent | Assay Description This assay determines the ability of a test compound to inhibit LSD-1 demethylase activity. E. coli expressed full-length human LSD-1 (Accession numb... | US Patent US10328077 (2019) BindingDB Entry DOI: 10.7270/Q2W66P3N | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Lysine-specific histone demethylase 1A (Homo sapiens (Human)) | BDBM283296 (4-[2-(4-amino-piperidin-1-yl)-5- (1H-indazol-6-yl)...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <100 | n/a | n/a | n/a | n/a | n/a | n/a |
Celgene Corporation US Patent | Assay Description This assay determines the ability of a test compound to inhibit LSD-1 demethylase activity. E. coli expressed full-length human LSD-1 (Accession numb... | US Patent US10328077 (2019) BindingDB Entry DOI: 10.7270/Q2W66P3N | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Lysine-specific histone demethylase 1A (Homo sapiens (Human)) | BDBM283298 (4-[2-((4S,3R)-4-amino-3-fluoro- piperidin-1-yl)-5-...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <100 | n/a | n/a | n/a | n/a | n/a | n/a |
Celgene Corporation US Patent | Assay Description This assay determines the ability of a test compound to inhibit LSD-1 demethylase activity. E. coli expressed full-length human LSD-1 (Accession numb... | US Patent US10328077 (2019) BindingDB Entry DOI: 10.7270/Q2W66P3N | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Lysine-specific histone demethylase 1A (Homo sapiens (Human)) | BDBM283302 (4-[5-(6-dimethylamino-pyridin-3- yl)-1-methyl-2-(4...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <100 | n/a | n/a | n/a | n/a | n/a | n/a |
Celgene Corporation US Patent | Assay Description This assay determines the ability of a test compound to inhibit LSD-1 demethylase activity. E. coli expressed full-length human LSD-1 (Accession numb... | US Patent US10328077 (2019) BindingDB Entry DOI: 10.7270/Q2W66P3N | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Lysine-specific histone demethylase 1A (Homo sapiens (Human)) | BDBM283305 (4-[2-(4-dimethylamino-piperidin-1- yl)-5-(2H-indaz...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <100 | n/a | n/a | n/a | n/a | n/a | n/a |
Celgene Corporation US Patent | Assay Description This assay determines the ability of a test compound to inhibit LSD-1 demethylase activity. E. coli expressed full-length human LSD-1 (Accession numb... | US Patent US10328077 (2019) BindingDB Entry DOI: 10.7270/Q2W66P3N | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Lysine-specific histone demethylase 1A (Homo sapiens (Human)) | BDBM289945 (4-[2-(4-aminopiperidin-1-yl)- 5-(1H-indazol- 5-yl)...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <100 | n/a | n/a | n/a | n/a | n/a | n/a |
Celgene Corporation US Patent | Assay Description This assay determines the ability of a test compound to inhibit LSD-1 demethylase activity. E. coli expressed full-length human LSD-1 (Accession numb... | US Patent US10328077 (2019) BindingDB Entry DOI: 10.7270/Q2W66P3N | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Lysine-specific histone demethylase 1A (Homo sapiens (Human)) | BDBM289955 (4-[2-(4-aminopiperidin- 1-yl)-5-[4-(2- methoxyetho...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <100 | n/a | n/a | n/a | n/a | n/a | n/a |
Celgene Corporation US Patent | Assay Description This assay determines the ability of a test compound to inhibit LSD-1 demethylase activity. E. coli expressed full-length human LSD-1 (Accession numb... | US Patent US10328077 (2019) BindingDB Entry DOI: 10.7270/Q2W66P3N | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Lysine-specific histone demethylase 1A (Homo sapiens (Human)) | BDBM283231 (2-(4-amino-piperidin-1-yl)-4-(4- cyano-3-fluoro-ph...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <100 | n/a | n/a | n/a | n/a | n/a | n/a |
Celgene Corporation US Patent | Assay Description This assay determines the ability of a test compound to inhibit LSD-1 demethylase activity. E. coli expressed full-length human LSD-1 (Accession numb... | US Patent US10328077 (2019) BindingDB Entry DOI: 10.7270/Q2W66P3N | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Lysine-specific histone demethylase 1A (Homo sapiens (Human)) | BDBM283258 (4-[2-(4-amino-piperidin-1-yl)-1- methyl-6-oxo-5-(1...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <100 | n/a | n/a | n/a | n/a | n/a | n/a |
Celgene Corporation US Patent | Assay Description This assay determines the ability of a test compound to inhibit LSD-1 demethylase activity. E. coli expressed full-length human LSD-1 (Accession numb... | US Patent US10328077 (2019) BindingDB Entry DOI: 10.7270/Q2W66P3N | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Lysine-specific histone demethylase 1A (Homo sapiens (Human)) | BDBM283261 (4-{5-(3-fluoro-4-methoxy-phenyl)- 1-methyl-6-oxo-2...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <100 | n/a | n/a | n/a | n/a | n/a | n/a |
Celgene Corporation US Patent | Assay Description This assay determines the ability of a test compound to inhibit LSD-1 demethylase activity. E. coli expressed full-length human LSD-1 (Accession numb... | US Patent US10328077 (2019) BindingDB Entry DOI: 10.7270/Q2W66P3N | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Lysine-specific histone demethylase 1A (Homo sapiens (Human)) | BDBM283264 (2-fluoro-4-[5-(3-fluoro- 4-methoxy-phenyl)-1-methy...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <100 | n/a | n/a | n/a | n/a | n/a | n/a |
Celgene Corporation US Patent | Assay Description This assay determines the ability of a test compound to inhibit LSD-1 demethylase activity. E. coli expressed full-length human LSD-1 (Accession numb... | US Patent US10328077 (2019) BindingDB Entry DOI: 10.7270/Q2W66P3N | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Lysine-specific histone demethylase 1A (Homo sapiens (Human)) | BDBM283266 (4-[2-(4-amino-piperidin-1-yl)- 2'-dimethylamino-1-...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <100 | n/a | n/a | n/a | n/a | n/a | n/a |
Celgene Corporation US Patent | Assay Description This assay determines the ability of a test compound to inhibit LSD-1 demethylase activity. E. coli expressed full-length human LSD-1 (Accession numb... | US Patent US10328077 (2019) BindingDB Entry DOI: 10.7270/Q2W66P3N | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Lysine-specific histone demethylase 1A (Homo sapiens (Human)) | BDBM283278 (4-[2-[1,4]diazepan-1-yl-5-(6- methoxy-pyridin-3-yl...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <100 | n/a | n/a | n/a | n/a | n/a | n/a |
Celgene Corporation US Patent | Assay Description This assay determines the ability of a test compound to inhibit LSD-1 demethylase activity. E. coli expressed full-length human LSD-1 (Accession numb... | US Patent US10328077 (2019) BindingDB Entry DOI: 10.7270/Q2W66P3N | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Lysine-specific histone demethylase 1A (Homo sapiens (Human)) | BDBM283283 (4-[2-[1,4]diazepan-1-yl-1-methyl- 5-(2-methyl-2H-i...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <100 | n/a | n/a | n/a | n/a | n/a | n/a |
Celgene Corporation US Patent | Assay Description This assay determines the ability of a test compound to inhibit LSD-1 demethylase activity. E. coli expressed full-length human LSD-1 (Accession numb... | US Patent US10328077 (2019) BindingDB Entry DOI: 10.7270/Q2W66P3N | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Lysine-specific histone demethylase 1A (Homo sapiens (Human)) | BDBM283285 (4-[2-(4-amino-piperidin-1-yl)-1- methyl-5-(6-morph...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <100 | n/a | n/a | n/a | n/a | n/a | n/a |
Celgene Corporation US Patent | Assay Description This assay determines the ability of a test compound to inhibit LSD-1 demethylase activity. E. coli expressed full-length human LSD-1 (Accession numb... | US Patent US10328077 (2019) BindingDB Entry DOI: 10.7270/Q2W66P3N | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Lysine-specific histone demethylase 1A (Homo sapiens (Human)) | BDBM283293 (4-[2-(4-amino-piperidin-1-yl)-1- methyl-5-(1-methy...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <100 | n/a | n/a | n/a | n/a | n/a | n/a |
Celgene Corporation US Patent | Assay Description This assay determines the ability of a test compound to inhibit LSD-1 demethylase activity. E. coli expressed full-length human LSD-1 (Accession numb... | US Patent US10328077 (2019) BindingDB Entry DOI: 10.7270/Q2W66P3N | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Lysine-specific histone demethylase 1A (Homo sapiens (Human)) | BDBM283300 (4-[2'-dimethylamino-2-(4- dimethylamino-piperidin-...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <100 | n/a | n/a | n/a | n/a | n/a | n/a |
Celgene Corporation US Patent | Assay Description This assay determines the ability of a test compound to inhibit LSD-1 demethylase activity. E. coli expressed full-length human LSD-1 (Accession numb... | US Patent US10328077 (2019) BindingDB Entry DOI: 10.7270/Q2W66P3N | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Lysine-specific histone demethylase 1A (Homo sapiens (Human)) | BDBM283216 (4-[2-(4-amino-piperidin-1-yl)-5- (3-fluoro-4-metho...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <100 | n/a | n/a | n/a | n/a | n/a | n/a |
Celgene Corporation US Patent | Assay Description This assay determines the ability of a test compound to inhibit LSD-1 demethylase activity. E. coli expressed full-length human LSD-1 (Accession numb... | US Patent US10328077 (2019) BindingDB Entry DOI: 10.7270/Q2W66P3N | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Lysine-specific histone demethylase 1A (Homo sapiens (Human)) | BDBM289950 (4-[2-(4-aminopiperidin- 1-yl)-5-(6-ethoxy-5- fluor...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <100 | n/a | n/a | n/a | n/a | n/a | n/a |
Celgene Corporation US Patent | Assay Description This assay determines the ability of a test compound to inhibit LSD-1 demethylase activity. E. coli expressed full-length human LSD-1 (Accession numb... | US Patent US10328077 (2019) BindingDB Entry DOI: 10.7270/Q2W66P3N | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Lysine-specific histone demethylase 1A (Homo sapiens (Human)) | BDBM342196 (4-[2-(4-aminopiperidin-1-yl)-5-[4-(2- hydroxyethox...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <100 | n/a | n/a | n/a | n/a | n/a | n/a |
Celgene Corporation US Patent | Assay Description This assay determines the ability of a test compound to inhibit LSD-1 demethylase activity. E. coli expressed full-length human LSD-1 (Accession numb... | US Patent US10328077 (2019) BindingDB Entry DOI: 10.7270/Q2W66P3N | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Lysine-specific histone demethylase 1A (Homo sapiens (Human)) | BDBM289957 (4-[2-(4-aminopiperidin-1-yl)- 5-[4-(hydroxymethyl)...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <100 | n/a | n/a | n/a | n/a | n/a | n/a |
Celgene Corporation US Patent | Assay Description This assay determines the ability of a test compound to inhibit LSD-1 demethylase activity. E. coli expressed full-length human LSD-1 (Accession numb... | US Patent US10328077 (2019) BindingDB Entry DOI: 10.7270/Q2W66P3N | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Lysine-specific histone demethylase 1A (Homo sapiens (Human)) | BDBM342206 (4-[2-(4-aminopiperidin-1-yl)-5- (4-chlorophenyl)-1...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <100 | n/a | n/a | n/a | n/a | n/a | n/a |
Celgene Corporation US Patent | Assay Description This assay determines the ability of a test compound to inhibit LSD-1 demethylase activity. E. coli expressed full-length human LSD-1 (Accession numb... | US Patent US10328077 (2019) BindingDB Entry DOI: 10.7270/Q2W66P3N | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Lysine-specific histone demethylase 1A (Homo sapiens (Human)) | BDBM283331 (4-[2-(4-aminopiperidin-1-yl)-1- methyl-6-oxopyrimi...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <100 | n/a | n/a | n/a | n/a | n/a | n/a |
Celgene Corporation US Patent | Assay Description This assay determines the ability of a test compound to inhibit LSD-1 demethylase activity. E. coli expressed full-length human LSD-1 (Accession numb... | US Patent US10328077 (2019) BindingDB Entry DOI: 10.7270/Q2W66P3N | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Lysine-specific histone demethylase 1A (Homo sapiens (Human)) | BDBM283333 (4-[2-(4-amino-piperidin-1-yl)-1- cyclopropylmethyl...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <100 | n/a | n/a | n/a | n/a | n/a | n/a |
Celgene Corporation US Patent | Assay Description This assay determines the ability of a test compound to inhibit LSD-1 demethylase activity. E. coli expressed full-length human LSD-1 (Accession numb... | US Patent US10328077 (2019) BindingDB Entry DOI: 10.7270/Q2W66P3N | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Lysine-specific histone demethylase 1A (Homo sapiens (Human)) | BDBM289979 (4-[2-(4-aminopiperidin-1-yl)-5-(4-methoxyphenyl)-6...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <100 | n/a | n/a | n/a | n/a | n/a | n/a |
Celgene Corporation US Patent | Assay Description This assay determines the ability of a test compound to inhibit LSD-1 demethylase activity. E. coli expressed full-length human LSD-1 (Accession numb... | US Patent US10328077 (2019) BindingDB Entry DOI: 10.7270/Q2W66P3N | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Lysine-specific histone demethylase 1A (Homo sapiens (Human)) | BDBM283225 (US10023543, Example 15 | US10207999, Example 15 | ...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <100 | n/a | n/a | n/a | n/a | n/a | n/a |
Celgene Corporation US Patent | Assay Description This assay determines the ability of a test compound to inhibit LSD-1 demethylase activity. E. coli expressed full-length human LSD-1 (Accession numb... | US Patent US10328077 (2019) BindingDB Entry DOI: 10.7270/Q2W66P3N | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Lysine-specific histone demethylase 1A (Homo sapiens (Human)) | BDBM283244 (4-[2-((3S)-3-amino-piperidin-1- yl)-5-(4-methoxy-p...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <100 | n/a | n/a | n/a | n/a | n/a | n/a |
Celgene Corporation US Patent | Assay Description This assay determines the ability of a test compound to inhibit LSD-1 demethylase activity. E. coli expressed full-length human LSD-1 (Accession numb... | US Patent US10328077 (2019) BindingDB Entry DOI: 10.7270/Q2W66P3N | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Lysine-specific histone demethylase 1A (Homo sapiens (Human)) | BDBM283250 (4-[2-(4-amino-piperidin-1-yl)-1- methyl-5-(1-methy...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <100 | n/a | n/a | n/a | n/a | n/a | n/a |
Celgene Corporation US Patent | Assay Description This assay determines the ability of a test compound to inhibit LSD-1 demethylase activity. E. coli expressed full-length human LSD-1 (Accession numb... | US Patent US10328077 (2019) BindingDB Entry DOI: 10.7270/Q2W66P3N | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Lysine-specific histone demethylase 1A (Homo sapiens (Human)) | BDBM283252 (4-[2-(4-aminopiperidyl)-1-methyl- 5-(2-methyl(2H-i...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <100 | n/a | n/a | n/a | n/a | n/a | n/a |
Celgene Corporation US Patent | Assay Description This assay determines the ability of a test compound to inhibit LSD-1 demethylase activity. E. coli expressed full-length human LSD-1 (Accession numb... | US Patent US10328077 (2019) BindingDB Entry DOI: 10.7270/Q2W66P3N | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Lysine-specific histone demethylase 1A (Homo sapiens (Human)) | BDBM283268 (2-fluoro-4-{5-(4-methoxy-phenyl)- 1-methyl-6-oxo-2...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <100 | n/a | n/a | n/a | n/a | n/a | n/a |
Celgene Corporation US Patent | Assay Description This assay determines the ability of a test compound to inhibit LSD-1 demethylase activity. E. coli expressed full-length human LSD-1 (Accession numb... | US Patent US10328077 (2019) BindingDB Entry DOI: 10.7270/Q2W66P3N | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Lysine-specific histone demethylase 1A (Homo sapiens (Human)) | BDBM283274 (4-[2-(4-amino-piperidin-1-yl)-5- (6-dimethylamino-...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <100 | n/a | n/a | n/a | n/a | n/a | n/a |
Celgene Corporation US Patent | Assay Description This assay determines the ability of a test compound to inhibit LSD-1 demethylase activity. E. coli expressed full-length human LSD-1 (Accession numb... | US Patent US10328077 (2019) BindingDB Entry DOI: 10.7270/Q2W66P3N | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Lysine-specific histone demethylase 1A (Homo sapiens (Human)) | BDBM283277 (4-[2-(4-amino-piperidin-1-yl)-1- methyl-6-oxo-5-(6...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <100 | n/a | n/a | n/a | n/a | n/a | n/a |
Celgene Corporation US Patent | Assay Description This assay determines the ability of a test compound to inhibit LSD-1 demethylase activity. E. coli expressed full-length human LSD-1 (Accession numb... | US Patent US10328077 (2019) BindingDB Entry DOI: 10.7270/Q2W66P3N | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Lysine-specific histone demethylase 1A (Homo sapiens (Human)) | BDBM283279 (4-[2-[1,4]diazepan-1-yl-5-(6- methoxy-pyridin-3-yl...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <100 | n/a | n/a | n/a | n/a | n/a | n/a |
Celgene Corporation US Patent | Assay Description This assay determines the ability of a test compound to inhibit LSD-1 demethylase activity. E. coli expressed full-length human LSD-1 (Accession numb... | US Patent US10328077 (2019) BindingDB Entry DOI: 10.7270/Q2W66P3N | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Lysine-specific histone demethylase 1A (Homo sapiens (Human)) | BDBM283282 (2-fluoro-4-[1-methyl-2- (4-methylamino-piperidin-1...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <100 | n/a | n/a | n/a | n/a | n/a | n/a |
Celgene Corporation US Patent | Assay Description This assay determines the ability of a test compound to inhibit LSD-1 demethylase activity. E. coli expressed full-length human LSD-1 (Accession numb... | US Patent US10328077 (2019) BindingDB Entry DOI: 10.7270/Q2W66P3N | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Lysine-specific histone demethylase 1A (Homo sapiens (Human)) | BDBM283284 (4-[2-[1,4]diazepan-1-yl-5- (6-dimethylamino-pyridi...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <100 | n/a | n/a | n/a | n/a | n/a | n/a |
Celgene Corporation US Patent | Assay Description This assay determines the ability of a test compound to inhibit LSD-1 demethylase activity. E. coli expressed full-length human LSD-1 (Accession numb... | US Patent US10328077 (2019) BindingDB Entry DOI: 10.7270/Q2W66P3N | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Lysine-specific histone demethylase 1A (Homo sapiens (Human)) | BDBM283289 (2-fluoro-4-[5-(4-methoxy-phenyl)- 1-methyl-2-(3-me...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <100 | n/a | n/a | n/a | n/a | n/a | n/a |
Celgene Corporation US Patent | Assay Description This assay determines the ability of a test compound to inhibit LSD-1 demethylase activity. E. coli expressed full-length human LSD-1 (Accession numb... | US Patent US10328077 (2019) BindingDB Entry DOI: 10.7270/Q2W66P3N | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Lysine-specific histone demethylase 1A (Homo sapiens (Human)) | BDBM283301 (4-[2-(4-dimethylamino-piperidin-1- yl)-1-methyl-5-...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <100 | n/a | n/a | n/a | n/a | n/a | n/a |
Celgene Corporation US Patent | Assay Description This assay determines the ability of a test compound to inhibit LSD-1 demethylase activity. E. coli expressed full-length human LSD-1 (Accession numb... | US Patent US10328077 (2019) BindingDB Entry DOI: 10.7270/Q2W66P3N | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Lysine-specific histone demethylase 1A (Homo sapiens (Human)) | BDBM289948 (4-[2-(4-aminopiperidin-1- yl)-5-[3-fluoro-4- (meth...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <100 | n/a | n/a | n/a | n/a | n/a | n/a |
Celgene Corporation US Patent | Assay Description This assay determines the ability of a test compound to inhibit LSD-1 demethylase activity. E. coli expressed full-length human LSD-1 (Accession numb... | US Patent US10328077 (2019) BindingDB Entry DOI: 10.7270/Q2W66P3N | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Lysine-specific histone demethylase 1A (Homo sapiens (Human)) | BDBM289949 (4-[2-[4- (dimethylamino)piperidin- 1-yl]-5-(6-meth...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <100 | n/a | n/a | n/a | n/a | n/a | n/a |
Celgene Corporation US Patent | Assay Description This assay determines the ability of a test compound to inhibit LSD-1 demethylase activity. E. coli expressed full-length human LSD-1 (Accession numb... | US Patent US10328077 (2019) BindingDB Entry DOI: 10.7270/Q2W66P3N | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Lysine-specific histone demethylase 1A (Homo sapiens (Human)) | BDBM342195 (4-[2-(4-aminopiperidin-1-yl)-5- (4-ethoxyphenyl)-1...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <100 | n/a | n/a | n/a | n/a | n/a | n/a |
Celgene Corporation US Patent | Assay Description This assay determines the ability of a test compound to inhibit LSD-1 demethylase activity. E. coli expressed full-length human LSD-1 (Accession numb... | US Patent US10328077 (2019) BindingDB Entry DOI: 10.7270/Q2W66P3N | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Lysine-specific histone demethylase 1A (Homo sapiens (Human)) | BDBM283341 (2-(4-amino-piperidin-1-yl)-3- methyl-5-(1-methyl-1...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 550 | n/a | n/a | n/a | n/a | n/a | n/a |
Celgene Corporation US Patent | Assay Description This assay determines the ability of a test compound to inhibit LSD-1 demethylase activity. E. coli expressed full-length human LSD-1 (Accession numb... | US Patent US10328077 (2019) BindingDB Entry DOI: 10.7270/Q2W66P3N | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Lysine-specific histone demethylase 1A (Homo sapiens (Human)) | BDBM283334 (2-(4-amino-piperidin-1-yl)-6-(4- chloro-3-fluoro-p...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 550 | n/a | n/a | n/a | n/a | n/a | n/a |
Celgene Corporation US Patent | Assay Description This assay determines the ability of a test compound to inhibit LSD-1 demethylase activity. E. coli expressed full-length human LSD-1 (Accession numb... | US Patent US10328077 (2019) BindingDB Entry DOI: 10.7270/Q2W66P3N | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Lysine-specific histone demethylase 1A (Homo sapiens (Human)) | BDBM283231 (2-(4-amino-piperidin-1-yl)-4-(4- cyano-3-fluoro-ph...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 550 | n/a | n/a | n/a | n/a | n/a | n/a |
Celgene Corporation US Patent | Assay Description This assay determines the ability of a test compound to inhibit LSD-1 demethylase activity. E. coli expressed full-length human LSD-1 (Accession numb... | US Patent US10328077 (2019) BindingDB Entry DOI: 10.7270/Q2W66P3N | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Lysine-specific histone demethylase 1A (Homo sapiens (Human)) | BDBM283227 (4-[2-(4-amino-piperidin-1-yl)-1- (3-hydroxy-propyl...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 550 | n/a | n/a | n/a | n/a | n/a | n/a |
Celgene Corporation US Patent | Assay Description This assay determines the ability of a test compound to inhibit LSD-1 demethylase activity. E. coli expressed full-length human LSD-1 (Accession numb... | US Patent US10328077 (2019) BindingDB Entry DOI: 10.7270/Q2W66P3N | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Lysine-specific histone demethylase 1A (Homo sapiens (Human)) | BDBM283338 (2-(4-amino-piperidin-1-yl)-6-(4- fluoro-phenyl)-3-...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 550 | n/a | n/a | n/a | n/a | n/a | n/a |
Celgene Corporation US Patent | Assay Description This assay determines the ability of a test compound to inhibit LSD-1 demethylase activity. E. coli expressed full-length human LSD-1 (Accession numb... | US Patent US10328077 (2019) BindingDB Entry DOI: 10.7270/Q2W66P3N | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Lysine-specific histone demethylase 1A (Homo sapiens (Human)) | BDBM283223 (4-[2-(4-amino-piperidin-1-yl)-1- ethyl-6-oxo-1,6-d...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 550 | n/a | n/a | n/a | n/a | n/a | n/a |
Celgene Corporation US Patent | Assay Description This assay determines the ability of a test compound to inhibit LSD-1 demethylase activity. E. coli expressed full-length human LSD-1 (Accession numb... | US Patent US10328077 (2019) BindingDB Entry DOI: 10.7270/Q2W66P3N | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Lysine-specific histone demethylase 1A (Homo sapiens (Human)) | BDBM283254 (4-[2-(4-aminopiperidyl)-6-(4- cyano-3-fluorophenyl...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 550 | n/a | n/a | n/a | n/a | n/a | n/a |
Celgene Corporation US Patent | Assay Description This assay determines the ability of a test compound to inhibit LSD-1 demethylase activity. E. coli expressed full-length human LSD-1 (Accession numb... | US Patent US10328077 (2019) BindingDB Entry DOI: 10.7270/Q2W66P3N | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Lysine-specific histone demethylase 1A (Homo sapiens (Human)) | BDBM283332 (4-[2-(4-amino-piperidin-1-yl)-1- cyclopropylmethyl...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 550 | n/a | n/a | n/a | n/a | n/a | n/a |
Celgene Corporation US Patent | Assay Description This assay determines the ability of a test compound to inhibit LSD-1 demethylase activity. E. coli expressed full-length human LSD-1 (Accession numb... | US Patent US10328077 (2019) BindingDB Entry DOI: 10.7270/Q2W66P3N | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Lysine-specific histone demethylase 1A (Homo sapiens (Human)) | BDBM283342 (2-(4-amino-piperidin-1-yl)-6-(4- methoxy-phenyl)-3...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 5.50E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Celgene Corporation US Patent | Assay Description This assay determines the ability of a test compound to inhibit LSD-1 demethylase activity. E. coli expressed full-length human LSD-1 (Accession numb... | US Patent US10328077 (2019) BindingDB Entry DOI: 10.7270/Q2W66P3N | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Lysine-specific histone demethylase 1A (Homo sapiens (Human)) | BDBM283259 (3-[2-(4-amino-piperidin-1-yl)-4- (4-cyano-3-fluoro...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 5.50E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Celgene Corporation US Patent | Assay Description This assay determines the ability of a test compound to inhibit LSD-1 demethylase activity. E. coli expressed full-length human LSD-1 (Accession numb... | US Patent US10328077 (2019) BindingDB Entry DOI: 10.7270/Q2W66P3N | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Lysine-specific histone demethylase 1A (Homo sapiens (Human)) | BDBM283340 (2-(4-amino-piperidin-1-yl)-5-(3- fluoro-4-methoxy-...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 5.50E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Celgene Corporation US Patent | Assay Description This assay determines the ability of a test compound to inhibit LSD-1 demethylase activity. E. coli expressed full-length human LSD-1 (Accession numb... | US Patent US10328077 (2019) BindingDB Entry DOI: 10.7270/Q2W66P3N | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Lysine-specific histone demethylase 1A (Homo sapiens (Human)) | BDBM283345 (2-(4-amino-piperidin-1-yl)-5-(3- fluoro-4-methoxy-...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 5.50E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Celgene Corporation US Patent | Assay Description This assay determines the ability of a test compound to inhibit LSD-1 demethylase activity. E. coli expressed full-length human LSD-1 (Accession numb... | US Patent US10328077 (2019) BindingDB Entry DOI: 10.7270/Q2W66P3N | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Lysine-specific histone demethylase 1A (Homo sapiens (Human)) | BDBM283336 (2-(4-amino-piperidin-1-yl)-6-(4- hydroxy-phenyl)-3...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
Celgene Corporation US Patent | Assay Description This assay determines the ability of a test compound to inhibit LSD-1 demethylase activity. E. coli expressed full-length human LSD-1 (Accession numb... | US Patent US10328077 (2019) BindingDB Entry DOI: 10.7270/Q2W66P3N | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Lysine-specific histone demethylase 1A (Homo sapiens (Human)) | BDBM283339 (2-(4-amino-piperidin-1-yl)-3- methyl-5-(1-methyl-1...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
Celgene Corporation US Patent | Assay Description This assay determines the ability of a test compound to inhibit LSD-1 demethylase activity. E. coli expressed full-length human LSD-1 (Accession numb... | US Patent US10328077 (2019) BindingDB Entry DOI: 10.7270/Q2W66P3N | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Lysine-specific histone demethylase 1A (Homo sapiens (Human)) | BDBM283344 (2-[2-(4-aminopiperidin-1-yl)-5-(3- fluoro-4-methox...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
Celgene Corporation US Patent | Assay Description This assay determines the ability of a test compound to inhibit LSD-1 demethylase activity. E. coli expressed full-length human LSD-1 (Accession numb... | US Patent US10328077 (2019) BindingDB Entry DOI: 10.7270/Q2W66P3N | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Lysine-specific histone demethylase 1A (Homo sapiens (Human)) | BDBM283343 (3-[2-(4-aminopiperidin-1-yl)-5-(3- fluoro-4-methox...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
Celgene Corporation US Patent | Assay Description This assay determines the ability of a test compound to inhibit LSD-1 demethylase activity. E. coli expressed full-length human LSD-1 (Accession numb... | US Patent US10328077 (2019) BindingDB Entry DOI: 10.7270/Q2W66P3N | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
